Thursday, November 20, 2008 - 11:00PM EST

Clinical Trials

11. Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.

Author
Scahill L; McDougle CJ; Williams SK; Dimitropoulos A; Aman MG; McCracken JT; Tierney E; Arnold LE; Cronin P; Grados M; Ghuman J; Koenig K; Lam KS; McGough J; Posey DJ; Ritz L; Swiezy NB; Vitiello B;
Institution
Yale Child Study Center, Yale University, New Haven, CT 06520, USA. lawrence.scahill@yale.edu
Journal
J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1114-23.
Abstract URL
Click here to view abstract

12. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder.

Author
Sousa MB; Isolan LR; Oliveira RR; Manfro GG; Cordioli AV;
Institution
Postgraduate Program in Medical Science, Psychiatry, Federal University of Rio Grande do Sul and the Anxiety Disorder Program, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.
Journal
J Clin Psychiatry. 2006 Jul;67(7):1133-9.
Abstract URL
Click here to view abstract

13. Clinical predictors of response to pharmacotherapy with selective serotonin reuptake inhibitors in obsessive-compulsive disorder.

Author
Tukel R; Bozkurt O; Polat A; Genc A; Atli H;
Institution
Department of Psychiatry, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. rtukel@superonline.com
Journal
Psychiatry Clin Neurosci. 2006 Aug;60(4):404-9.
Abstract URL
Click here to view abstract

14. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches.

Author
Storch EA; Geffken GR; Merlo LJ; Mann G; Duke D; Munson M; Adkins J; Grabill KM; Murphy TK; Goodman WK;
Institution
Department of Psychiatry, University of Florida, Gainesville, FL 32610, USA. estorch@psychiatry.ufl.edu
Journal
J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):469-78.
Abstract URL
Click here to view abstract

15. Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study.

Author
Stein DJ; Andersen EW; Tonnoir B; Fineberg N;
Institution
University of Cape Town, Republic of South Africa. dan.stein@uct.ac.za
Journal
Curr Med Res Opin. 2007 Apr;23(4):701-11.
Abstract URL
Click here to view abstract

16. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.

Author
Stewart SE; Fagerness JA; Platko J; Smoller JW; Scharf JM; Illmann C; Jenike E; Chabane N; Leboyer M; Delorme R; Jenike MA; Pauls DL;
Institution
Psychiatric Neurodevelopmental and Genetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Journal
Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144(8):1027-33.
Abstract URL
Click here to view abstract

17. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS).

Author
Mantovani A; Lisanby SH; Pieraccini F; Ulivelli M; Castrogiovanni P; Rossi S;
Institution
Department of Neuroscience, Section of Psychiatry, Section of Neurophysiology, Postgraduate School in Applied Neurological Sciences, Siena University, Siena, Italy. am2518@columbia.edu
Journal
Int J Neuropsychopharmacol. 2006 Feb;9(1):95-100. Epub 2005 Jun 28.
Abstract URL
Click here to view abstract

18. High-dose escitalopram for the treatment of obsessive-compulsive disorder.

Author
Rabinowitz I; Baruch Y; Barak Y;
Institution
The YOTAM Treatment Center, Ramat-Gan bAbarbanel Mental Health Center, Bat-Yam, Israel.
Journal
Int Clin Psychopharmacol. 2008 Jan;23(1):49-53.
Abstract URL
Click here to view abstract
Pages: 1 2 3